Zach Frye is a principal scientist at Skyhook, with prior experience as a principal scientist at Resonance Medicine, Inc. and a senior scientist at Sana Biotechnology, Inc. They contributed to antibody discovery at Compass Therapeutics LLC from 2016 to 2019. Frye completed a Ph.D. in Chemical Engineering at The University of Texas at Austin, where they also served as a graduate research assistant. Earlier in their career, they gained valuable experience through internships and co-op positions in various biotech and chemical companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices